Πλοήγηση ανά Συγγραφέα "Kerenidi, T."
Αποτελέσματα 1-20 από 23
-
Angiogenesis: Antiangiogenesis strategy and angiogenesis inhibitors
(2010)Angiogenesis is the development of new blood vessels from preexisting vasculature. The angiogenic process is controlled by the net balance between molecules with positive and negative regulatory activity. In the past three ... -
Anti-survivin antibody responses in lung cancer
(2009)Existing evidence regarding spontaneous anti-survivin humoral responses in lung cancer is inconclusive. Moreover, despite that cancer cell death elicited by radiotherapy and some chemotherapeutic agents seems to be ... -
Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals
(2008)Survivin and its variant survivin-2B have been considered as potential candidates for cancer immunotherapy. The magnitude however of spontaneously occurring CD8+ T cells circulating precursor CTLs (pCTL), has never been ... -
Clinical significance of serum adipokines levels in lung cancer
(2013)Adipokines have a significant effect on metabolism, immunoinflammatory responses as well as on carcinogenesis; therefore, we aimed at evaluating their potential predictive and prognostic significance in lung cancer. Eighty ... -
Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects
(2010)Background: This study aimed to examine whether EBV seropositive patients with lung cancer have an altered virus-specific CTL response, as compared to age-matched healthy controls and whether any variation in this response ... -
Differential expression of hypoxia-inducible factor 1 alpha in non-small cell lung cancer and small cell lung cancer
(2012)OBJECTIVES: The aim of this study was to compare the expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in small cell lung cancer and subtypes of non-small cell lung cancer and examine ... -
Foxp3 expression in human cancer cells
(2008)Objective: Transcription factor forkhead box protein 3 (Foxp3) specifically characterizes the thymically derived naturally occurring regulatory T cells (Tregs). Limited evidence indicates that it is also expressed, albeit ... -
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer
(2007)Background: The expression of indoleamine 2,3-dioxygenase (IDO) by tumor cells has been considered as a major tumor immune escape mechanism. The aim of this study was to investigate the expression of IDO in lung cancer ... -
Long-term respiratory follow-up of H1N1 infection
(2011)Background: The first case of 2009 pandemic influenza A (H1N1) virus infection was documented in our Hospital on 10th August 2009. Metdods and findings: Real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) ... -
Mesothelioma mortality in Greece from 1983 to 2003
(2009)To present summary statistics of the Greek mesothelioma epidemic including summaries by occupation and geographical area. The National Statistics Service provides our data, which contain all deaths from 1983 to 2003 where ... -
Naturally occurring tumor-specific CD8(+) T-cell precursors in individuals with and without cancer
(2010)Boosting pre-existing, naturally occurring cytolytic CD8(+) T-cell (CTLs) responses directed against class-I MHC-restricted peptides of tumor antigens, represents a primary goal of cancer immunotherapy. The number of ... -
Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer
(2008)Vascular endothelial growth factor (VEGF) is known to play crucial rote in tumour angiogenesis. It is demonstrated that VEGF can be up-regulated by oxidative stress. The aim of this study was to determine the serum VEGF ...